PNNL

Abstract

PNNL wins 4 Technology Transfer Awards Pacific Northwest National Laboratory has received four 2006 Excellence in Technology Transfer Awards from the Federal Laboratory Consortium - a nationwide network of more than 700 major federal laboratories and centers as well as their parent departments and agencies that provides a forum to develop strategies and opportunities for linking technology with the mission and the marketplace. The FLC presents its Awards for Excellence in Technology Transfer to federal laboratory employees who have done outstanding work in transferring U.S. government-sponsored technologies to the public and private sectors. Since 1984, when the awards program was established, Pacific Northwest has earned 62 of these awards, far more than any other national laboratory. This year, PNNL won all four of the nominations that were submitted - the most that any laboratory can submit. PNNL was recognized for transferring technologies that treat and cure cancer, uniquely analyze massive sets of data, increase surgical implant success rates, and neutralize toxic chemicals from the environment. Through collaboration with PNNL researchers and access to facilities at PNNL, IsoRay Medical, Inc. (http://www.isoray.com), expanded its brachytherapy technology for treating prostate and other cancers. The medical isotope “seed” products are available at more than 17 implant centers nationwide. More than 40 organizations, including Fortune 500 companies, are using the Starlight information visualization software to mine and interpret massive amounts of data. Bacterin International licensed bioactive thin-film coatings which reduce infection rates associated with surgical implants. Self-Assembled Monolayers on Mesoporous Silica (SAMMS), a process for removing mercury and other toxic chemicals from the environment, was licensed to Steward Advanced Materials for use in coal-fired power plants, municipal incinerators, and other plants.